Anebulo Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
Anebulo Pharmaceuticals, Inc. Earnings Date And Information
Anebulo Pharmaceuticals, Inc. last posted its earnings results on Wednesday, September 25th, 2024. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.13 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Anebulo Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -5.21. Anebulo Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based on prior year's report dates.
Anebulo Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q1 2025 | -$0.08 | $0 | $0 | ||
| 09/25/2024 | Q4 2024 | -$0.13 | -$0.05 | 0.08 | $0 | $0 |
| 05/15/2024 | Q3 2024 | -$0.11 | -$0.06 | 0.05 | $0 | |
| 02/13/2024 | Q2 2024 | -$0.11 | -$0.11 | 0 | $0 | |
| 11/14/2023 | Q1 2024 | -$0.11 | -$0.10 | 0.01 | $0 | |
| 09/22/2023 | Q4 2023 | -$0.10 | $0 | |||
| 05/11/2023 | Q3 2023 | -$0.16 | -$0.11 | 0.05 | $0 | |
| 02/10/2023 | Q2 2023 | -$0.11 | -$0.15 | -0.04 | $0 | |
| 11/10/2022 | Q1 2023 | -$0.10 | -$0.11 | -0.01 | $0 | |
| 06/30/2022 | Q4 2022 | -$0.10 | $0 | |||
| 05/11/2022 | Q3 2022 | -$0.05 | -$0.08 | -0.03 | $0 | |
| 02/11/2022 | Q2 2022 | -$0.06 | -$0.05 | 0.01 | $0 | |
| 11/12/2021 | Q1 2022 | -$0.07 | $0 | |||
| 09/22/2021 | Q4 2021 | -$0.00 | -$1.59 | -1.59 | $0 | |
| 06/21/2021 | Q3 2021 | -$0.04 | -$0.02 | 0.02 | $0 | |
| 12/31/2020 | Q2 2021 | -$0.01 | $0 | |||
| 09/30/2020 | Q1 2021 | -$0.01 | $0 |
Anebulo Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Anebulo Pharmaceuticals, Inc.'s earnings date?
Anebulo Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based off last year's report dates.
-
Did Anebulo Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Anebulo Pharmaceuticals, Inc. (:ANEB) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.08.
-
How can I listen to Anebulo Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Anebulo Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Anebulo Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Anebulo Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Anebulo Pharmaceuticals, Inc. generate each year?
Anebulo Pharmaceuticals, Inc. (:ANEB) has a recorded net income of $0. Anebulo Pharmaceuticals, Inc. has generated $-0.32 earnings per share over the last four quarters.
-
What is Anebulo Pharmaceuticals, Inc.'s price-to-earnings ratio?
Anebulo Pharmaceuticals, Inc. (:ANEB) has a price-to-earnings ratio of -5.21 and price/earnings-to-growth ratio is 0.35.
